(Q53189881)
Statements
1 reference
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. (English)
1 reference
B H O'Neil
1 reference
A J Scott
1 reference
W W Ma
1 reference
S J Cohen
1 reference
L Leichman
1 reference
D L Aisner
1 reference
A R Menter
1 reference
M A Tejani
1 reference
J K Cho
1 reference
J Granfortuna
1 reference
L Coveler
1 reference
O O Olowokure
1 reference
J C Baranda
1 reference
M Cusnir
1 reference
P Phillip
1 reference
J Boles
1 reference
R Nazemzadeh
1 reference
M Rarick
1 reference
D J Cohen
1 reference
J Radford
1 reference
L Fehrenbacher
1 reference
R Bajaj
1 reference
V Bathini
1 reference
P Fanta
1 reference
J Berlin
1 reference
A J McRee
1 reference
R Maguire
1 reference
F Wilhelm
1 reference
M Maniar
1 reference
A Jimeno
1 reference
C L Gomes
1 reference
W A Messersmith
1 reference
21 October 2015
1 reference
1 reference
26
1 reference
12
1 reference
2505
1 reference
Identifiers
1 reference
1 reference